skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Measurement of endothelial function and its clinical utility for cardiovascular risk

Review

(3095) Views  (884) Full article downloads

Authors: Mo Al-Qaisi, Rajesh K Kharbanda, Tarun K Mittal, Ann E Donald

Published Date June 2008 Volume 2008:4(3) Pages 647 - 652
DOI: http://dx.doi.org/10.2147/VHRM.S2769

Mo Al-Qaisi1, Rajesh K Kharbanda1, Tarun K Mittal1, Ann E Donald2

1Royal Brompton and Harefield NHS Trust, London, UK; 2Institute of Child Health and Great Ormond Street Hospital, NHS Trust, London, UK

Abstract: Over the past two decades, the central role of the endothelium in the initiation, progression, and clinical sequelae of atherosclerosis has been increasingly recognized. Assessment of the pathobiology of the endothelium and its ability to act as a potential therapeutic target remains an area of active research interest. Whilst endothelial function has been shown to be a marker for risk of cardiovascular events in high-risk groups, there remains considerable debate about the most appropriate way to assess this. We discuss the different clinical methods to assess endothelial function, focusing on flow-mediated dilatation (FMD) of the brachial artery, highlighting the importance of using a standardized methodology, as well as discussing the clinical limitations of using FMD in individuals.

Keywords: endothelial function, flow-mediated dilatation, clinical utility, cardiovascular risk






 

Other articles by Dr Mo Al-Qaisi



Readers of this article also read:

Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Potential renovascular hypertension, space missions, and the role of magnesium
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation
Everolimus-eluting stents: update on current clinical studies
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University